These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3533174)

  • 1. [Comparative study of the properties of a proteolytic enzyme isolated from the myelin of animals and from the biological fluids of disseminated sclerosis patients].
    Khokhlov AP; Baskaeva TS; Khrustaleva NA
    Biull Eksp Biol Med; 1986 Oct; 102(10):430-2. PubMed ID: 3533174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new highly active proteolytic myelin enzyme and its possible role in the mechanism of the demyelinating process].
    Savchenko IuN; Zavalishin IA; Zakharova MN; Khrustaleva NA; Khokhlov AP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):49-53. PubMed ID: 2718665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation and various properties of leucine aminopeptidase from biological fluids of patients with multiple sclerosis].
    Khokhlov AP; Baskaeva TS; Khrustaleva NA; Zavalishin IA; Mozzhechkov VT
    Vopr Med Khim; 1987; 33(2):58-62. PubMed ID: 3604142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis.
    Sato S; Quarles RH; Brady RO; Tourtellotte WW
    Ann Neurol; 1984 Mar; 15(3):264-7. PubMed ID: 6202231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes.
    Banik NL
    Crit Rev Neurobiol; 1992; 6(4):257-71. PubMed ID: 1384994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.
    Cuzner ML; Davison AN; Rudge P
    Ann Neurol; 1978 Oct; 4(4):337-44. PubMed ID: 83119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic (encephalitogenic) proteins as vulnerable part in early myelin breakdown.
    Frey HJ; Laarksonen H; Riekkinen PJ; Rinne UK
    Acta Neurol Scand Suppl; 1972; 51():371-3. PubMed ID: 4514354
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proteolytic activity of nerve tissue].
    Belik IaV; Smerchinskaia LS; Terletskaia IaT; Grinenko AG
    Ukr Biokhim Zh; 1968; 40(6):543-8. PubMed ID: 5735203
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycerophosphorylcholine phosphocholine phosphodiesterase activity of rat brain myelin.
    Kanfer JN; McCartney DG
    J Neurosci Res; 1989 Oct; 24(2):231-40. PubMed ID: 2555532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions to enzyme histochemistry of the experimental demyelination.
    Gabrielescu E
    Rev Roum Physiol; 1969; 6(1):45-54. PubMed ID: 5403633
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic degradation of myelin basic protein in central nervous system lesions of monkeys with experimental allergic encephalomyelitis.
    Rauch HC; Einstein ER; Csejtey J
    Neurobiology; 1973; 3(3):195-205. PubMed ID: 4124846
    [No Abstract]   [Full Text] [Related]  

  • 12. Degradation of myelin proteins by brain endogenous neutral protease.
    Singh I; Singh AK
    Neurosci Lett; 1983 Aug; 39(1):77-82. PubMed ID: 6195561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ATPase activity in purified myelin from peripheral nerves. II. Effect of proteolytic and lipasic enzymes].
    Cavallotti C
    Boll Soc Ital Biol Sper; 1969 Feb; 45(4):241-4. PubMed ID: 4242200
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of calpain-1 in myelin and microglia in the white matter of the aged rhesus monkey.
    Hinman JD; Duce JA; Siman RA; Hollander W; Abraham CR
    J Neurochem; 2004 Apr; 89(2):430-41. PubMed ID: 15056286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteolytic enzymes in multiple sclerosis].
    Piccoli F; Savettieri G
    Riv Neurol; 1979; 49(3):253-8. PubMed ID: 112668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein turnover in myelin and mitochondrial fractions.
    Marks N; Lajtha A
    Vopr Biokhim Mozga; 1972; 7(0):43-54. PubMed ID: 4679757
    [No Abstract]   [Full Text] [Related]  

  • 17. The inhibitory effect of multiple sclerosis and control sera on certain myelin-catabolizing enzymes.
    Norstrand IF; Druck P
    Ann Neurol; 1977 Jul; 2(1):84-5. PubMed ID: 900914
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
    Miller DJ; Asakura K; Rodriguez M
    J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients.
    Rozniecki JJ; Hauser SL; Stein M; Lincoln R; Theoharides TC
    Ann Neurol; 1995 Jan; 37(1):63-6. PubMed ID: 7818259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.